• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Confidentiality in a Time of COVID

Confidentiality in a Time of COVID

September 3, 2020
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

There are two sets of laws governing the release of substance abuse information. One requires the patient’s signature for all disclosures, while the other takes a more liberal approach.


The liberal branch is the Health Insurance Portability and Accountability Act (HIPAA), which allows disclosures without the patient’s consent to “covered entities” (eg, doctors, therapists, pharmacists, and insurers who are paying for the patient’s care). The Substance Abuse and Mental Health Services Administration (SAMHSA) has a different take on confidentiality, requiring signed consent before disclosures related to substance use disorders. Most, but not all, psychiatric providers fall under SAMHSA’s umbrella.


Does SAMHSA Govern Your Practice?
SAMHSA law applies to group and individual practices that meet #1 and #2:



  1. “Holds itself out” (eg, advertises) as providing treatment or referrals for alcohol or drug abuse

  2. Is certified by the federal government or receives federal support, including any of the following:

    • Uses a DEA license to prescribe controlled substances for the treatment of substance use disorders

    • Receives any federal funding, including Medicare payments, even if the funding is unrelated to the treatment of substance use disorders

    • Is granted tax exempt status by the IRS




On July 13, 2020, SAMHSA modernized the law to allow disclosure without patient consent during emergencies that result from a natural disaster. COVID-19 is included alongside hurricanes and floods in the list, though the opioid crisis is not. Further updates to the law are planned for 2021.

General Psychiatry
    www.thecarlatreport.com
    Issue Date: September 3, 2020
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - When to Use Lithium, TCPR, September 2020
    Highlights From This Issue
    How COVID-19 Affects the Brain
    Who Should Get Lithium?
    Modern Challenges of Delusional Disorder
    Two Augmentation Strategies Compared in Bipolar I
    Confidentiality in a Time of COVID
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.